Medical Sciences

About the Journal

The Indo Eurasian Journal of Medical Sciences (IEJMS) is a comprehensive, open-access, double-blind peer-reviewed periodical published bi-monthly by Scienceroot Publishers. The journal is dedicated to advancing clinical, translational, biomedical, and public health research across the Indo-Eurasian region and the broader global medical community. Operating with a commitment to rapid publication and rigorous academic standards, IEJMS serves as a critical multidisciplinary platform for researchers, academicians, clinicians, and healthcare policymakers. By fostering global collaboration and ensuring open access to essential medical literature, the publication actively supports the dissemination of high-quality scientific findings that drive modern medicine forward.

The scientific scope of the journal is intentionally broad, encompassing three primary domains of medical research and practice. Within the clinical sciences, the journal prioritizes the publication of rigorous clinical trials, detailed case reports, and studies focused on evidence-based patient care, spanning specialties such as surgery, pharmacology, therapeutics, nursing, and allied health. The life sciences sector emphasizes foundational biomedical research, seeking significant contributions in areas including genetics, microbiology, and biochemistry. Furthermore, the public health division addresses large-scale population health dynamics, covering epidemiology, community medicine, and the development of preventive health policy.

To maintain the highest levels of scientific integrity, IEJMS strictly adheres to comprehensive publication ethics, malpractice guidelines, and stringent plagiarism policies. The editorial and advisory boards are committed to a thorough and equitable peer-review process, ensuring that all published work meets the rigorous criteria expected of premier medical colleges and research institutions. Ultimately, the journal aims to bridge the gap between foundational biomedical engineering and direct patient care, accelerating the translation of laboratory discoveries into effective clinical treatments and measurably improving community health outcomes worldwide.